OVERVIEW
Each year in the United States there are approximately 64,000 new diagnoses of type 1 diabetes (T1D), the second most common childhood disease. Approximately 25% of newly diagnosed patients present with life-threatening diabetic ketoacidosis, which is a result of acute, severe hyperglycemia, suggesting that T1D may be unrecognized until overt hyperglycemia occurs. In this virtual symposium, we will learn about the importance of early identification of children at risk and the immune agents that can delay the decline in beta cell function.
Enhance Your Virtual Experience With Backstage Pass!
Join our 30-minute post-symposium breakout session connecting the program speakers and audience in the virtual environment. Backstage Pass provides an intimate virtual session where you can interact with faculty, address case-based questions, and facilitate relationship building.
*Video Encouraged*
GOAL STATEMENT
The goal of this activity is that learners will be better able to screen for and stage T1D.
LEARNING OBJECTIVES
Upon completion of this activity, participants will: Have increased knowledge regarding the [list][item]Recommendations for screening and staging pediatric patients at risk for T1D [item]Continued follow-up after diagnosis for patients with T1D [/list]Have greater competence related to: [list][item]Screening and staging pediatric patients at high risk for T1D[/list]
ACCREDITATION STATEMENT
In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [MEDSCAPE] [JALOGO]
[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 1.0 [italic][bold]AMA PRA Category 1 Credit(s)™[/bold][/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Nurses[/bold] Awarded 1.0 contact hour(s) of nursing continuing professional development for RNs and APNs.
Supported by an educational grant from [bold]Provention Bio, Inc.[/bold]